
Abuse of Performance Enhancing Agents, Weight Loss (Semaglutide)
A Deep Dive into Complex Addiction Cases with Leading Experts! The ACMT Addiction Toxicology Case Conference webinar series discusses Addiction/Toxicology cases in an interactive fashion featuring experts from Addiction Medicine, Addiction Psychiatry, and Medical Toxicology.
Case 1: Athlete Using Online Antibolic and Growth Hormone Releasing Peptides
Case 2: Performance Enhancing GLP-1s: Altering Appearance with Counterfeit Semaglutide
Target Audience
This activity is designed for an audience of Physicians and Nurses
Learning Objectives
- List 3 performance-enhancing agents available through online and other sources commonly misused by athletes.
- Evaluate the impact of counterfeit GLP-1 agonists, including semaglutide, on performance enhancement and weight loss, and examine strategies for healthcare professionals to identify and mitigate the risks associated with their misuse.
Commercial Support
There is no commercial support for this activity.
Gloria J. Baciewicz, MD (Moderator) Addiction Psychiatrist, Strong Recovery Professor of Clinical Psychiatry, Department of Psychiatry, University of Rochester Medical Center, Rochester, NY | N/A | Nothing to disclose |
Michael B. Marlin, MD, Assistant Professor of Emergency Medicine, Medical Director, Mississippi Poison Control Center, University of Mississippi Medical Center | Novo Nordisk Eli Lilly | Individual stocks and stock options |
Stephanie T. Weiss, MD, PhD, Staff Research Physician, Translational Addiction Medicine Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health | N/A | Nothing to disclose |
Timothy J. Wiegand, MD, FACMT, DFASAM (Moderator) Director of Toxicology and of the Toxicology Consults University of Rochester Medical Center, Rochester, NY | N/A | Nothing to disclose |
Dorothy Caputo, MA, BSN, RN (President, AKH Inc.) | N/A | Nothing to disclose |
Michele Bielarski, RN (planner/reviewer) AKH Inc., Advancing Knowledge in Healthcare | N/A | Nothing to disclose |
AKH Inc Staff and Planners | N/A | Nothing to disclose |
ACMT Staff and Planners | N/A | Nothing to disclose |
All of the relevant financial relationships listed for these individuals have been mitigated. |
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with "Opt Out" in the subject line.
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and and American College of Medical Toxicology (ACMT). AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 1.25 Interprofessional Continuing Education (IPCE) credit for learning and change.
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this enduring material for a maximum of 1.25AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing
Credit being awarded: 1.25ANCC contact hours
Available Credit
- 1.25 AMA PRA Category 1 Credit™
- 1.25 ANCC
- 1.25 Attendance